To investigate if GRB2-mediated regulation of AGO2 could affect the cell cancer phenotype we performed migration assays in HEK293T cells which were overexpressing GFP-tagged AGO2 WT or the GRB2-binding-deficient mutant GFP-AGO2 4A (Fig. 2d). The gene discussed is GRB2; the disease is cancer.